AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment

Recruitingn/aAges 18 Years - anyAllUniversity of Salamanca
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to describe speech and breathing patterns in adults after acquired brain injury (ABI) and understand how these patterns relate to the presence, severity, and type of dysarthria. The main questions it aims to answer are: * What changes in voice and breathing are observed in adults with dysarthria after ABI? * Can combining acoustic, respiratory, and clinical assessments help identify dysarthria severity and subtype? Participants will: * Have their speech recorded to measure voice and articulation features, such as pitch, clarity, and the ability to sustain sounds. * Perform breathing tests using a spirometer to assess lung function. * Complete the Frenchay Dysarthria Assessment-2 (FDA-2), adapted to Spanish, to classify dysarthria type and severity. About 97 to 101 participants will take part. The results will help speech therapists better detec

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older at the time of enrollment. Diagnosed with acquired brain injury (ABI), including: * Stroke * Traumatic brain injury (TBI) * Brain tumor * Ability to provide written informed consent (or via a legally authorized representative if necessary). * Cognitive function preserved, defined as a Mini-Mental State Examination (MMSE) score โ‰ฅ 24. Exclusion Criteria: * History of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) or asthma. * History of hearing impairments that could affect speech evaluation. * Presence of additional neurological or neurodegenerative disorders other than the acquired brain injury. * History of voice disorders or dysphonia prior to the acquired brain injury. * Presence of persistent pharyngeal symptoms, such as mucus, secretions, or foreign body sensation, which may interfere with speech assessment. * Participants unable to comply with the assessment protocol or complete the required sessions. * Presence of apahasia that prevents participation in speech tasks, such as reading, repetition, or spontaneous speech priduction.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
University of Salamanca
Salamanca, Spain
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy